Effect of catatoxic steroids upon established morbid changes.
D000818:Animals; D004074:Digitoxin / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000506:poisoning; D005260:Female; D007213:Indomethacin / Q000009:adverse effects / Q000037:antagonists & inhibitors; D007421:Intestine, Small / Q000473:pathology; D009570:Nitriles / Q000494:pharmacology* / Q000627:therapeutic use; D010538:Peritonitis / Q000139:chemically induced / Q000188:drug therapy; D011041:Poisoning / Q000188:drug therapy; D011284:Pregnenolone / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy; D013148:Spironolactone / Q000008:administration & dosage / Q000494:pharmacology*
D009570:Nitriles; D013148:Spironolactone; D011284:Pregnenolone; D004074:Digitoxin; D007213:Indomethacin